Expanding the phenotype of Kleefstra syndrome: speech, language and cognition in 103 individuals.

Genetics, Behavioral Human Genetics Neurology Pediatrics Phenotype

Journal

Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R

Informations de publication

Date de publication:
30 Jan 2024
Historique:
received: 19 10 2023
accepted: 18 01 2024
medline: 31 1 2024
pubmed: 31 1 2024
entrez: 30 1 2024
Statut: aheadofprint

Résumé

Speech and language impairments are core features of the neurodevelopmental genetic condition Kleefstra syndrome. Communication has not been systematically examined to guide intervention recommendations. We define the speech, language and cognitive phenotypic spectrum in a large cohort of individuals with Kleefstra syndrome. 103 individuals with Kleefstra syndrome (40 males, median age 9.5 years, range 1-43 years) with pathogenic variants (52 9q34.3 deletions, 50 intragenic variants, 1 balanced translocation) were included. Speech, language and non-verbal communication were assessed. Cognitive, health and neurodevelopmental data were obtained. The cognitive spectrum ranged from average intelligence (12/79, 15%) to severe intellectual disability (12/79, 15%). Language ability also ranged from average intelligence (10/90, 11%) to severe intellectual disability (53/90, 59%). Speech disorders occurred in 48/49 (98%) verbal individuals and even occurred alongside average language and cognition. Developmental regression occurred in 11/80 (14%) individuals across motor, language and psychosocial domains. Communication aids, such as sign and speech-generating devices, were crucial for 61/103 (59%) individuals including those who were minimally verbal, had a speech disorder or following regression. The speech, language and cognitive profile of Kleefstra syndrome is broad, ranging from severe impairment to average ability. Genotype and age do not explain the phenotypic variability. Early access to communication aids may improve communication and quality of life.

Identifiants

pubmed: 38290825
pii: jmg-2023-109702
doi: 10.1136/jmg-2023-109702
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Lottie D Morison (LD)

Speech and Language, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Audiology and Speech Pathology, The University of Melbourne, Melbourne, Victoria, Australia.

Milou G P Kennis (MGP)

Department of Clinical Genetics, Radboudumc, Nijmegen, Netherlands.

Dmitrijs Rots (D)

Department of Clinical Genetics, Erasmus MC, Rotterdam, Netherlands.

Arianne Bouman (A)

Department of Clinical Genetics, Radboudumc, Nijmegen, Netherlands.

Joost Kummeling (J)

Department of Clinical Genetics, Radboudumc, Nijmegen, Netherlands.

Elizabeth Palmer (E)

Sydney Children's Hospital Network, Randwick, New South Wales, Australia.
Discipline of Paediatrics and Child Health, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.

Adam P Vogel (AP)

Department of Audiology and Speech Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
Redenlab, Melbourne, Victoria, Australia.

Frederique Liegeois (F)

Great Ormond Street Institute of Child Health, University College London, London, UK.

Amanda Brignell (A)

Department of Paediatrics, Monash University, Clayton, Victoria, Australia.
Department of Developmental Paediatrics, Monash Children's Hospital, Clayton, Victoria, Australia.

Siddharth Srivastava (S)

Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.

Zoe Frazier (Z)

Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.

Di Milnes (D)

Genetic Health Queensland, Herston, Queensland, Australia.

Himanshu Goel (H)

Hunter Genetics, Waratah, New South Wales, Australia.

David J Amor (DJ)

Speech and Language, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, Royal Children's Hospital, Parkville, Victoria, Australia.

Ingrid E Scheffer (IE)

Melbourne Brain Centre, Austin Health, Heidelberg, Victoria, Australia.
The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.

Tjitske Kleefstra (T)

Department of Clinical Genetics, Radboudumc, Nijmegen, Netherlands.
Department of Clinical Genetics, Erasmus MC, Rotterdam, Netherlands.

Angela T Morgan (AT)

Speech and Language, Murdoch Children's Research Institute, Parkville, Victoria, Australia angela.morgan@mcri.edu.au.
Department of Audiology and Speech Pathology, The University of Melbourne, Melbourne, Victoria, Australia.

Classifications MeSH